Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy.
暂无分享，去创建一个
L. Schwartz | T. Kuder | U. Haberkorn | C. Zechmann | F. Giesel | C. Kratochwil | F. Bruchertseifer | P. Flechsig | S. Wulfert